News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Biota Holdings Limited, GlaxoSmithKline Imports Additional Relenza To Japan
February 11, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Melbourne, Feb 11, 2009 (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that GlaxoSmithKline (LON:GSK) has advised of the current Relenza supply situation in respect to the key market of Japan.
Twitter
LinkedIn
Facebook
Email
Print
Asia
Australia
GlaxoSmithKline
MORE ON THIS TOPIC
Lung Cancer
Summit’s Bispecific Misses Survival Endpoint in Global Phase III Trial but Analysts Remain Optimistic
May 30, 2025
·
3 min read
·
Nick Paul Taylor
Collaboration
Astellas Keeps Chinese Collab Train Chugging With $1.5B+ Bet for Claudin ADC
May 30, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Novo Opposes Pharma Tariffs, Urges Crackdown on Illicit Chinese Semaglutide
May 29, 2025
·
2 min read
·
Tristan Manalac
China
Pfizer’s China Deal Worth up to $6B Eclipses Peers in a Frenzied Market
May 20, 2025
·
1 min read
·
Annalee Armstrong
